EX-99.2 34 ex99_2.htm EXHIBIT 99.2

American Boarding Company

Unaudited Pro Forma Balance Sheets

September 30, 2015

 

American Boarding Company
For the Year Ended
  Microlin Bio, Inc.
For the Year Ended
  Pro Forma  Consolidated
September 30, 2015  September 30, 2015  Adjustments  Pro Forma
ASSETS           
CURRENT ASSETS                   
Cash and cash equivalents $97   $1   $—     $98 
Prepaid expense  —      —      —      —   
Total Current Assets  97    1    —      98 
SECURITY DEPOSIT  —      8,000    —      8,000 
TOTAL ASSETS $97   $8,001   $—     $8,098 
LIABILITIES AND STOCKHOLDERS' DEFICIT                   
CURRENT LIABILITIES                   
Accounts payable and accrued expenses $5,231   $6,029,910   $—     $6,035,141 
Notes payable - Ohio State Innovation Foundation  —      2,446,213    —      2,446,213 
Convertible note payable - related party  18,868    —      —      18,868 
Due to officer  8,438    —      —      8,438 
Loans made by Founder  —      430,379    —      430,379 
Convertible notes payable, net of discount  23,423    —      —      23,423 
Derivative anti-dilution liability  —      752,700    —      752,700 
Total Current Liabilities  55,960    9,659,202    —      9,715,162 
STOCKHOLDERS' DEFICIT                   
Preferred stock, $0.001 par value;                   
10,000,000 shares authorized,                   
0 shares issued and outstanding  —      —      —      —   
Common stock, $0.001 par value;                   
90,000,000 shares authorized,                   
20,000,000 shares issued and outstanding  9,100    4    19,000(a)   20,000 
                  (8,100)(b)
                  (4)(c)
Stock Payable  32,100    —      (32,100)(d)   —   
Additional paid-in capital  269,737    2,638,164    (19,000)(a)   2,562,305 
                  8,100(b)
                  4(c)
                  32,100(d)
                  (366,800)(e)
Accumulated Deficit  (366,800)   (12,289,369)   366,800(e)   (12,289,369)
Total Stockholders' Deficit  (55,863)   (9,651,201)   —      (9,707,064)
TOTAL LIABILITIES AND                   
STOCKHOLDERS' DEFICIT $97   $8,001   $—     $8,098 

 

The accompanying notes are an integral part of these financial statements.

 1 
   

American Boarding Company

Unaudited Pro Forma Statements of Operations

September 30, 2015

 

   American Boarding Company
For the Nine Months Ended
  Microlin Bio, Inc.
For the Year Ended
  Pro Forma  Consolidated
   September 30, 2015  September 30, 2015  Adjustments  Pro Forma
             
REVENUES  $1,800   $—     $—     $1,800 
                     
OPERATING EXPENSES                    
                     
Research and development- principally costs to obtain patent portfolio   —      894,529    —      894,529 
Licenses and fees   2,122    —      —      2,122 
Professional fees   12,980    —      —      12,980 
General and administrative   885    985,485    —      986,370 
                     
Total Operating Expenses   15,987    1,880,014    —      1,896,001 
                     
Net Loss from Operation   (14,187)   (1,880,014)   —      (1,894,201)
                     
OTHER EXPENSE                    
Interest expense   10,313    85,617         95,930 
                     
Total Other Expenses   10,313    85,617    —      95,930 
                     
Net Loss Before Provision of Income Taxes   (24,500)   (1,965,631)   —      (1,990,131)
                     
Income taxes   —      —             
                     
NET LOSS  $(24,500)  $(1,965,631)  $—     $(1,990,131)
                     
BASIC AND DILUTED                    
   NET LOSS PER SHARE  $(0.00)  $(0.49)       $(0.10)
                     
  WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING   9,100,000    4,030,258         20,000,000 

 

The accompanying notes are an integral part of these financial statements. 

 2 
   

American Boarding Company

Notes to Pro Forma Financial Statements

(Unaudited)

 

Note 1 - INTRODUCTION

 

Merger

 

On  December __, 2015, American Boarding Company (“Boarding”) entered into a Share Exchange and Conversion Agreement (the “Exchange Agreement”) by and among Boarding and a holder of a majority of Boarding’s issued and outstanding capital stock (the “Majority Shareholder”), on the one hand, and Microlin Bio, Inc., a Delaware corporation (“Microlin”) and the shareholders of Microlin (“Microlin Stockholders”).

 

Pursuant to the share exchange, Boarding shall issue 19,000,000 restricted shares of its common stock, $0.001 par value per share, to the Microlin Stockholders in the aggregate, in exchange for 4,030,258 shares of Microlin common stock held by them, representing 100% of the then issued and outstanding share capital of Microlin (the “Share Exchange”).

 

The completion of the Share Exchange resulted in a change of control. The Share Exchange was accounted for as a reverse merger and recapitalization. Microlin was the acquirer for financial reporting purposes and Boarding was the acquired company.

 

Consequently, the assets and liabilities and the operations reflected in the historical financial statements prior to the Share Exchange were those of Microlin and was recorded at its historical cost basis; and the consolidated financial statements after completion of the Share Exchange included the assets and liabilities of Microlin and Boarding, the historical operations of Microlin .

  

Note 2 - PRO FORMA PRESENTATION

 

General

 

The following unaudited pro forma combined balance sheets and income statements are based on historical financial statements of Boarding as if the transaction had occurred during the period ended September 30, 2015, the date of accounting acquirer’s most recent period end.

 

The unaudited pro forma combined financial statements are provided for information purposes only. The pro forma financial statements are not necessarily indicative of what the financial position or results of operations actually would have been had the acquisition been completed at the dates indicated below. In addition, the unaudited pro forma combined financial statements do not purport to project the future financial position or operating results of the combined company. The unaudited pro forma combined financial information has been prepared in accordance with the rules and regulations of the Securities and Exchange Commission.

 

For pro forma purposes:

 

· The unaudited Pro Forma Combined Balance Sheets as of September 30, 2015 of the companies give effect to the transaction as if it had occurred on September 30, 2015 ; and

 

· The unaudited Pro Forma Combined Statements of Operations for the period ended September 30, 2015 combines the income statements of the companies for the indicated periods, giving effect to the transaction as if it had occurred on October 1, 2014.

 

Pro forma adjustments:

 

The unaudited pro forma balance sheet and statements of operations reflect the following adjustments associated with the Share Exchange between Boarding and Microlin:

 

(a)In connection with the Share Exchange Agreement, 4,030,258 shares of Microlin common stock were exchanged for 19,000,000 newly issued shares of Boarding common stock, and 8,100,000 shares of Boarding common stock were cancelled;
(b)8,100,000 shares of Boarding common stock were cancelled;
(c)Pro forma elimination of Microlin’s existing common stock;
(d)Stock payable of $32,100 were written off;
(e)Pro forma elimination of Boarding’s remaining holding deficit against Microlin’s accumulated paid in capital.

 

These unaudited pro forma combined financial statements and accompanying notes should be read in conjunction with the separate audited financial statements of Boarding and Microlin as of and for the period ended September 30, 2015.

 3